Urinary Self-Catheters Market Top Companies Analysis To growing at CAGR of 4.1% by 2026 | ConvaTec, Hollister, Inc.

UPDATE AVAILABLE ON-DEMAND

Urinary self-catheters are medical devices, which help to drain the urine in patients who lose control over their bladder and are unable to urinate naturally. The urinary self-catheters market is expected to experience significant growth during the forecast period, owing to rise in demand for hydrophilic intermittent catheter across geographies.

The global urinary self-catheters market size was valued at $1,722 million in 2018, and is expected to reach $2,387 million by 2026, growing at a CAGR of 4.1% from 2019 to 2026.

Download Free Report Sample @ https://www.alliedmarketresearch.com/request-sample/2768

Furthermore, surge in number of prostate surgeries; increase in prevalence of benign prostate hyperplasia, urinary incontinence, and spinal cord injuries; upsurge in geriatric population, and implementation of favorable reimbursement policies for usage of intermittent catheters boost the growth of the urinary self-catheters market during the forecast period. However, availability of alternatives for usage of self-catheters hampers the market growth.

COVID-19 scenario-

1) Due to the global pandemic all over the world, the medical devices manufacturers are majorly focusing on essential medical devices production including ventilators and diagnostics.

2) However, due to the precautionary measures taken by governments in various regions, the supply chain has been hampered. Which may result in shortage of devices in certain locations.

3) Food and Drugs Administration (FDA), on the other hand, shared a COVID-19 guidance with medical device manufacturers to notify the agency about changes that could affect availability of their products.

Based on product, the market is categorized as intermittent catheters and external catheters. At present, the intermittent catheters segment dominates the global market, and is anticipated to remain dominant during the forecast period. Some key factors that drive the growth of this segment include rise in demand for intermittent catheters, favorable reimbursement policies for usage of these catheters, wide availability of intermittent catheters at affordable price, and increase in target population.

Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/2768

Based on type, the global urinary self-catheters market is dominated by male type catheter, due to rise in prevalence of benign prostate hyperplasia (BPH), increase in number of prostate surgery, and surge in number of patients with urinary retention.

Based on application, spinal cord injuries segment was the major revenue contributor in 2018, owing to rise in incidence of spinal cord injuries and increase in adoption of self-intermittent catheters. However, the benign prostate hyperplasia segment is anticipated to exhibit the fastest growth during the forecast period, owing to increase in prevalence of benign prostate hyperplasia, rise in adoption of intermittent catheters, and surge in male geriatric population.

North America accounted for approximately one-half of the global urinary self-catheters market share in 2018, and is expected to remain dominant throughout the forecast period. This was attributed to rise in higher adoption of urinary self-catheters, presence of well-developed healthcare infrastructure, higher number of target population, wide availability of urinary self-catheter systems, and supportive reimbursement policies for usage of these catheter. However, Asia-Pacific is expected to experience the highest growth rate during the forecast period, majorly due to rise in target population along with increase in adoption of urinary self-catheter systems.

Access Full Report @ https://www.alliedmarketresearch.com/urinary-self-catheter-market

The Major Key Players Are:

• Asid Bonz GmbH
• B Braun Melsungen AG
• Becton Dickson and Company (C.R. Bard)
• Boston Scientific Corporation
• Coloplast A/S
• ConvaTec
• Hollister, Inc.
• Medical Technologies of Georgia, Inc.
• Medtronic Plc.
• Teleflex Incorporated.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.